DOCSLIB.ORG

Syllabus-And-Proceedings.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Syllabus-And-Proceedings.Pdf Courses How to Expand Your Practice With Telepsychiatry Director: Jay H. Shore, M.D., M.P.H. Thursday, October 19, 2017 Faculty: Peter M. Yellowlees, M.D., Robert Lee Caudill, M.D., Steven Chan, M.D., M.B.A. Buprenorphine and Office-Based Treatment of Opioid Use Disorder EDUCATIONAL OBJECTIVE: Director: John A. Renner, M.D. At the conclusion of this session, the participant Faculty: Petros Levounis, M.D., M.A., Andrew J. should be able to: 1) Understand how to select an Saxon, M.D. appropriate model of telepsychiatry care and develop an integration plan for to match EDUCATIONAL OBJECTIVE: telepsychiatry model into a specific practice setting; At the conclusion of this session, the participant 2) Understand methods for adapting telepsychiatry should be able to: 1) Discuss the rationale and need into various health care environments and solutions for medication-assisted treatment (MAT) of opioid and best methods of successful integration of use disorder; 2) Apply the pharmacological telepsychiatry into psychiatric practice; and 3) characteristics of opioids in clinical practice; 3) Comprehend how national standards and guidelines Describe buprenorphine protocols for all phases of for telepsychiatry, clinical workflows, e-treatment treatment and for optimal patient/treatment team coordination, and APPS can be best adopted matching; 4) Describe the legislative and regulatory for the creation of telepsychiatric practice. requirements of office-based opioid pharmacotherapy; and 5) Discuss treatment issues SUMMARY: and management of opioid use disorder in Telepsychiatry, in the form of live interactive adolescents, pregnant women, and patients with videoconferencing, has reached maturity as a field acute and/or chronic pain. and is being adapted in a wide variety of health care settings. It is demonstrating its ability to increase SUMMARY: access to care as well as shift models of health care This course will describe the resources needed to set delivery. There are now many demonstrated up office-based treatment with buprenorphine for successful models of providing telepsychiatric care. patients with opioid use disorder (OUD) and review Identifying the most appropriate model of 1) DSM-5 criteria for opioid use disorder and the telepsychiatry for subsequent adoption into an commonly accepted criteria for patients appropriate individual psychiatric practice or organization is for office-based treatment of OUD; 2) confidentiality critical for building scalable and sustainable services. rules related to treatment of substance use Successfully integration of telepsychiatry into an disorders; 3) Drug Enforcement Administration individual psychiatric practice or healthcare requirements for recordkeeping; 4) billing and organization requires careful planning, development, common office procedures; 5) the epidemiology, and implementation. There are a core sets of issues symptoms, and current treatment of anxiety, and challenges around clinical standards, workflow common depressive disorders, and ADHD and how and education that need to be address for successful to distinguish independent disorders from integration to occur. The course will be taught by substance-induced psychiatric disorders; and 6) psychiatric national experts in telepsychiatry in common clinical events associated with addictive highly interactive demonstration session with the behavior. Special treatment populations, including audience. The course instructors will take the adolescents, pregnant addicts, and geriatric, HIV- audience through the integration of telepsychiatry positive, and chronic pain patients will be addressed, into two hypothetical practice settings; 1) Home- and small-group case discussions will be used to based private psychiatry and 2) Integrated Care reinforce learning. Telepsychiatry service covering the salient administrative and clinical issues in the creation of Friday, October 20, 2017 such a practice. Administrative topics to be addressed will include needs assessment and planning, model selection, legal and regulatory and Mental Health" workshop will feature issues, resourcing and reimbursement and clinical presentations on: (1) an overview of the complex needs. Live interactive mock video conferencing connections between marijuana and mental health; sessions will highlight important clinical issues (2) medical marijuana, including pharmaceutical and including safety management, clinical process dispensary formulations, efficacy in treating physical adaptation to videoconferencing, managing hybrid and mental health conditions, dosing, interactions doctor-patient relationships and virtual team work. and monitoring; (3) synthetic cannabinoids, including physiological, physical and psychiatric effects; (4) Marijuana and Mental Health psychiatric complications of cannabis use, including Director: Dan Nguyen, M.D. impact on anxiety and mood disorders; (5) marijuana Faculty: Thida Thant, M.D., Marc Manseau, M.D., and psychosis; (6) short- and long-term effects of M.P.H., Taylor Black, M.D., Erica Rapp, M.D., Jesse cannabis use in adolescents; (7) legislation and policy Darrell Hinckley, M.D., Ph.D., Charles Luther, M.D. related to medical marijuana; and (8) the treatment of cannabis use disorder, including EDUCATIONAL OBJECTIVE: psychotherapeutic and pharmacological At the conclusion of this session, the participant interventions. should be able to: 1) Identify various dispensary and pharmaceutical formulations of medical marijuana Saturday, October 21, 2017 as well as synthetic cannabinoids; 2) Describe how cannabis use impacts psychiatric illnesses including 2017 Psychiatry Review and Clinical Synthesis mood disorders, anxiety and psychosis; 3) Recognize Directors: Philip R. Muskin, M.D., M.A., Tristan the short and long term effects of cannabis use in Gorrindo, M.D. adolescents; 4) Understand differences between Faculty: Ilse Wiechers, M.D., M.H.S., M.P.P., Ashley highlighted medical marijuana programs as well as Weiss, D.O., M.P.H., John W. Barnhill, M.D. the current state and implications of current legislation; and 5) Know treatments for acute EDUCATIONAL OBJECTIVE: cannabis intoxication and cannabis use disorder. At the conclusion of this session, the participant should be able to: 1) Identify gaps in knowledge in SUMMARY: psychiatry and neurology through self-assessment; Marijuana use is a controversial and provocative 2) List key diagnostic and treatment strategies for topic across the United States. Opinions about major disorders in psychiatry; 3) Create individual marijuana can range from it being a harmless natural learning plans for addressing knowledge gaps; and 4) plant with medicinal value while others view it as a Convey a working knowledge of the various topical substance of abuse with overstated benefits and areas likely to be encountered during lifelong understated risks. Despite the classification of learning activities. marijuana on a federal level, marijuana use is becoming legalized by states across the U.S. and SUMMARY: highlights the ambivalence about marijuana in our Using a "flipped classroom" design, participants will society. Research currently suggests increased engage in a multi-week self-study exercise designed teenage and adult use of marijuana in states with to increase knowledge and critical reasoning of legalized medical marijuana with noted harmful essential psychiatric and neurology topics. On effects for adolescents and those with psychotic August 15th, 2017, registered participants for this spectrum disorders. With the increasing prevalence course will receive by mail three textbooks. The first and availability of marijuana products, medical book, Study Guide for the Psychiatry Board providers will need to become more informed and Examination, consists of several hundred self-study well versed about marijuana beyond the scope of multiple-choice questions (MCQ) including answers addiction. This workshop will familiarize attendees and explanations. The second book is a curated with this new culture of legalized medical marijuana compendium of review articles from FOCUS: The and its implications for psychiatry. This "Marijuana Journal of Lifelong Learning, which have been compiled to summarize current diagnostic and disorders can have substantial impact on the treatment approaches for major disorders in affected children and their families, as well as across psychiatry. The third text is Approach to the systems including educational, medical, adult Psychiatric Patient, a case-based exploration of workforce, and juvenile justice. While there is psychiatric topics. Course participants are increasing evidence of the validity of many encouraged to use these materials to review major psychiatric disorders in children down to the topics in psychiatry prior to attending IPS: The preschool age, developmental differences exist, both Mental Health Services Conference. During the live while comparing children and adults, as well as portion of this course, participants will work in small within the pediatric population. Similarly, there are groups and with expert faculty in general psychiatry, important developmental differences in geriatric psychiatry, child psychiatry, and consult- psychopharmacological treatment approaches and liaison psychiatry to complete a series of case-based in the incidence of adverse effects. This course will vignettes that have been designed to illustrate high- provide an overview of recommended treatment yield and key learning points for major disorders in approaches for non-child and adolescent
Load more

Recommended publications
  • Normal Laboratory Values/Adult Patients
    Normal Laboratory Values/Adult Patients Clinical Chemistry Tests Lipid Panel Alanine aminotransferase 13–48 U/L Cholesterol, total 160–240 mg/dL (ALT, SGPT) HDL cholesterol >40 mg/dL Albumin 3.6–5.2 g/dL LDL cholesterol <130 mg/dL Alkaline phosphatase (ALP) 35–120 U/L Triglycerides 55–200 mg/dL Amylase, serum 44–128 U/L Aspartate aminotransferase 15–41 U/L (AST, SGOT) Bilirubin, conjugated 0–0.2 mg/dL Thyroid Function Tests Bilirubin, total 0.2–1.2 mg/dL Thyroid stimulating hormone (TSH) 2–11 μU/mL Calcium 8.5–10.5 mg/dL Thyroxine, free (FT4) 0.8–2.4 ng/dL Carbon dioxide (CO2), total 23–30 mEq/L Thyroxine, total (T ) 4.0–12.0 μg/dL Chloride 98–109 mEq/L 4 Triiodothyronine (T )70–200 ng/dL Creatine kinase (CK, CPK) 40–260 U/L 3 Triiodothyronine (T ) resin uptake 25–38% Creatinine 0.7–1.2 mg/dL 3 (T3RU) Gamma glutamyltransferase 5–40 U/L (GGT) Glucose, fasting 65–110 mg/dL Hemoglobin A1C 5.0–7.0% of total Hb Blood Gases Iron, serum 50–170 μg/dL Iron-binding capacity, total 270–390 μg/dL Arterial Venous (TIBC) Base excess À3.0 to À5.0 to Lactate, serum (venous) 5.0–20.0 mg/dL +3.0 mEq/L +5.0 mEq/L Lactate dehydrogenase (LDH) 110–260 U/L Bicarbonate 18–25 mEq/L 18–25 mEq/L Lipase 10–140 U/L (HCO3) – – Magnesium 1.5–2.5 mg/dL pO2 80 95 mm Hg 30 48 mm Hg – – Potassium 3.5–5.1 mEq/L O2 saturation 95 98 % 60 85 % – – Prostate-specific antigen 0–4 ng/mL pCO2 34 45 mm Hg 35 52 mm Hg – – Protein, total 6.1–7.9 g/dL Total CO2 23 30 mEq/L 24 31 mEq/L – – Sodium 136–147 mEq/L pH 7.35 7.45 7.32 7.42 Troponin I <2.5 ng/mL Troponin T <0.2 ng/mL Urea nitrogen 6.0–20.0 mg/dL Hematology and Coagulation Tests Uric acid 2.6–7.2 mg/dL White blood cell (WBC) 4.4–11.0 K/mm3 count Hemoglobin 12.2–15.0 g/dL (continued) # Springer International Publishing Switzerland 2017 1811 P.M.
    [Show full text]
  • A Review of Delusions of Parasitosis, Part 1: Presentation and Diagnosis
    CONTINUING MEDICAL EDUCATION A Review of Delusions of Parasitosis, Part 1: Presentation and Diagnosis Rachel Bak, MD; Phani Tumu, MD; Christina Hui, MD; David Kay, BA; Julie Burnett; David Peng, MD GOAL To understand delusions of parasitosis (DOP) to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Identify criteria for diagnosing DOP. 2. Describe features associated with DOP. 3. Discuss possible causes of DOP. CME Test on page 136. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. July 2008. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Bak, Tumu, Hui, and Peng; Mr. Kay; and Ms. Burnett report no conflict of interest. The authors report no discussion of off-label use. Dr. Fisher reports no conflict of interest. Delusions of parasitosis (DOP), a psychiatric and treatment with psychotropic medications. We disorder in which patients erroneously insist discuss the classification, epidemiology, clinical that they are infested with parasites, remains a presentation, etiology, associated features, and fascinating entity with elusive origins.
    [Show full text]
  • PERAN PSIKONEUROALERGOLOGI PADA DERMATOLOGI Dr. Dr. Cita
    PERAN PSIKONEUROALERGOLOGI PADA DERMATOLOGI Dr. dr. Cita Rosita Sigit Prakoeswa, Sp.KK(K), FINSDV, FAADV Bagian Kulit dan Kelamin FK UNAIR/RSUD Dr Soetomo Surabaya Abstrak Psikoneuroimunologi adalah sebuah interdisiplin ilmu dengan fokus komunikasi biokimia antara otak, perilaku dan sistem imun. Psikoneuroalergologi merupakan turunan Psikoneuroimunologi yang lebih memfokuskan pada keterkaitan alergi imunologi dengan faktor psikososial. Peningkatan manifestasi alergi diduga berhubungan dengan faktor-faktor lingkungan seperti stres. Berbagai penelitian telah dilakukan dan terbukti adanya disfungsi hipotalamus- hipofisis-adrenal (HPA) dalam respon terhadap stres dapat memfasilitasi penyimpangan sistem imun dan dengan demikian, dapat meningkatkan risiko sensitisasi dan eksaserbasi alergi terutama dalam kondisi stres. Secara klinis dan fisiologis telah dapat dijelaskan mengenai stres psikologis yang merupakan kontributor penting pada perjalanan penyakit alergi melalui efeknya secara langsung maupun tidak langsung terhadap respon imun, ekspresi neuropeptide kulit, dan fungsi sawar kulit. Kata kunci: psikoneuroimunologi, psikoneuroalergologi, hipotalamus-hipofisis-adrenal Abstract Psychoneuroimmunology is an inter disiplinary field that specifically examines the biochemical cross talk between brain, behavior and the immune system. Psychoneuroallergology at the cross road between allergy immunology concept and psycosocial factors. The increase of allergic manifestation may be associated with environmental factors such as stress. A growing number
    [Show full text]
  • Hi There, Spooky Family! Before I Begin, I’D Like to Apologise for Reading from Notes I Prepared Beforehand
    Hi there, Spooky family! Before I begin, I’d like to apologise for reading from notes I prepared beforehand. I’m afraid my memory is not as young as it used to be, and to embark on a talk of this length without a memory aid would be very difficult for me to even attempt now. If you saw John White’s SAMA webinar on biofeedback last week, you’ll be aware that I’m presently in China right now for reasons that will be shared with you all later in the year. So with Echo’s encouragement, by which I really mean prodding, I thought I’d take the opportunity to talk about myself - my least favourite subject by a country mile! You’ve probably noticed that my initials - DB - appear in the titles of many of the Spooky2 factory presets. Feedback from Spooky2 users tells us that our presets work very effectively, and our thousands of testimonials give very powerful witness to that. For this, we must thank our expert preset builders - John White (JW), Jeff Kaczor (JK), Bryan Yamamoto (BY), Manuel Mallo (MM), Walt Dod (WD), Ed Von (EV), and David Halliday (DH). I think almost all of our preset builders knew quite a bit about Rife therapy when Spooky was launched. And John White had actually designed and built several Rife machines before starting his Spooky journey. I, pn the other hand, will freely admit that I knew virtually nothing about Rife beyond the fact that it worked. When my first Spooky rig arrived on my doorstep, I was completely bamboozled, and I had to make several posts on the forum we used at that time to seek help on how to connect it, then set everything up correctly.
    [Show full text]
  • How to Get Your Life Back from Morgellons, Chronic Lyme, and Other Skin Parasites Limited Edition
    How to Get Your Life Back from Morgellons, Chronic Lyme, and Other Skin Parasites Limited Edition Unraveling the Connection Between Chronic Lyme & Morgellons By Richard Kuhns B.S.Ch.E. Tenth Printing Self Published 2006, 2011, 2012, 2014, 2015, 2016, 2017, 2020 By Get Your Life Back LLC 28 Tindall Rd. Middletown, NJ 07748 732-531-1178 1-800-993-0929 Cover art by Jonquelyne Kalmbach King DietSM is a service mark owned by Get Your Life Back LLC Middletown, NJ Nature's Gift® is a registered trade mark owned by Get Your Life Back LLC Middletown, NJ This book may not be reproduced or transmitted in whole or in part through any means electronic or mechanical including photo copying or electronic transmission without prior written permission from the author, except as considered normal for review. Disclaimer and Terms of Use: The Author and Publisher has striven to be as accurate and complete as possible in the creation of this book, notwithstanding the fact that he does not warrant or represent at any time that the contents within are accurate due to the rapidly changing nature of the subject matter. While all attempts have been made to verify information provided in this publication, the Author and Publisher assumes no responsibility for errors, omissions, or contrary interpretation of the subject matter herein. Any perceived slights of specific persons, peoples, or organizations are unintentional. In practical advice books, like anything else in life, there are no guarantees. Note: the FDA has not evaluated the information contained in this book. This information is for educational purposes only.
    [Show full text]
  • {Replace with the Title of Your Dissertation}
    Power Shifts: How Patient Activism Shapes the Practice of Medicine A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Susan Parry IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Carl Elliott, Adviser November 2008 © Susan Parry 2008 i Acknowledgements I would like to thank my committee members Carl Elliott, Debra DeBruin, Jeff Kahn, and Valerie Tiberius, all of whom have been invaluable mentors and friends. Carl Elliott, my adviser, has been helpful and supportive beyond measure. I have had the pleasure of spending most of my time in graduate school at the Center for Bioethics at the University of Minnesota, directed by Jeff Kahn. I would like to thank all the Center faculty and staff for their direction and support during my years as a research assistant and especially in the last eighteen months as I returned to complete this dissertation. The Department of Philosophy also deserves my gratitude for a generous Swenson- Kierkegaard fellowship. Many family members and friends have helped along the way. Most of all, I would like to thank my husband Bill Vann whose love, friendship, and support not only made completing this project possible, but made it worthwhile. ii For my children Wilson, Willa, and Oscar iii Abstract This dissertation examines specific phenomena that illustrate a unique aspect of the role of patient activism in shaping the practice of medicine. Each chapter focuses on a specific example. The four examples are the rise of Morgellons disease, activism by sufferers of chronic Lyme disease, research subject activism, and the use of patients to market Paxil for social phobia.
    [Show full text]
  • Sawbones 369: the Parasite Delusion Published 25Th May 2021 Listen Here on Themcelroy.Family
    Sawbones 369: The Parasite Delusion Published 25th May 2021 Listen here on themcelroy.family Clint: Sawbones is a show about medical history, and nothing the hosts say should be taken as medical advice or opinion. It’s for fun. Can’t you just have fun for an hour and not try to diagnose your mystery boil? We think you’ve earned it. Just sit back, relax and enjoy a moment of distraction from that weird growth. You’re worth it. [theme music plays] Justin: Hello everybody, and welcome to Sawbones: a marital tour of misguided medicine. I’m your cohost, Justin McElroy [whispers] and I feel great. Sydnee: And I’m Sydnee McElroy. Justin: Friday, right? Sydnee: Yeah? Justin: Woo! Sydnee: Feeling good? You happy? Justin: Feeling good, feeling Friday. Got that sun outside. Sydnee: Yeah, this warm weather is— yes. It is— Justin: Energized. Got my D, got my C, that’s coffee. Sydnee: I’m growing plants outside again. Justin: Yeah! You said they’re starting to perk up a little bit, too. You were a little frustrated. Sydnee: I know, I was so worried. I was so worried my herbs were not responding well at the beginning of the season and I thought— there was the frost where I didn’t get them in and they got snowed on and oh, I thought they were done for. Justin: Yeah. Sydnee: But they’re growing again so all is well. They just had to chill? I don’t know. Justin: If you think it would be— Sydnee: [laughs] I don’t know anything about that.
    [Show full text]
  • Lyme Disease After My Teenage Daughter Became Very Ill with It
    A FACTUAL GUIDE BY THE WORLD'S LEADING CLINICAL EXPERT MORGELLONS: THE LEGITIMIZATION OF A DISEASE Dr. Ginger Savely Disclaimer: The information in this book is not intended as a substitute for medical counseling. The author does not assume liability for any loss, damage, or injury caused or alleged to be caused directly or indirectly by the information contained in or omitted from this book. Copyright © 2016 by Virginia Riley Savely Library of Congress Cataloging-in-Publication Data is available on file. All Rights Reserved. No part of this book may be reproduced in any manner without the express written consent of the author, except in the case of brief excerpts in critical reviews or articles. In an effort to keep sales prices down, this book has been printed in black and white. Please visit www.gingersavely.com/morgellons-book to access color versions of all photographs. Cover design by Ruben de Haas Cover photo credit Denise Moudree ISBN E-Book: 978-0-9979200-0-0 Pap erback: 978-0-9979200-2-4 Printed in the United States of America DEDICATION Travis Wilson was one of many “orphan patients” abandoned by the health care system because he did not have the good fortune to contract a known and socially accepted disease. To Travis, for the loss of his young life, and to the many other Morgellons patients who have suffered in isolation and fear, I dedicate this work. FOREWORD There is a rapidly growing interest in Morgellons disease as evidenced by the fact that research papers on the topic have been among the most highly accessed scientific research on the Internet for the past few years.
    [Show full text]
  • Troublesome Disguises Managing Challenging Disorders in Psychiatry
    Troublesome disguises Managing challenging disorders in psychiatry Troublesome disguises Managing challenging disorders in psychiatry EDITED BY Dinesh Bhugra Professor of Mental Health and Cultural Diversity Institute of Psychiatry, King’s College London London, UK Gin S. Malhi Professor and Chair Department of Psychiatry Sydney Medical School University of Sydney Sydney, Australia SECOND EDITION This edition first published 1997 © 2015 by John Wiley & Sons, Ltd. Registered Office John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial Offices 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 1606 Golden Aspen Drive, Suites 103 and 104, Ames, Iowa 50010, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners.
    [Show full text]